Education
About Us
Working with TipRanks
Follow Us
Clover Health Investments (CLOV)
NASDAQ:CLOV
CLOV Stock Chart & Stats
$2.50
-$0.09(-2.50%)
At close: 4:00 PM EST
$2.50
-$0.09(-2.50%)
Day’s Range― - ―
52-Week Range$2.12 - $4.87
Previous CloseN/A
Volume2.53M
Average Volume (3M)9.15M
Market Cap
$1.29B
Enterprise Value$1.57B
Total Cash (Recent Filing)$201.04M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.50
Next Earnings
Mar 04, 2026EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding424,304,900
10 Day Avg. Volume4,506,981
30 Day Avg. Volume9,153,863
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)4.52
Price to Sales (P/S)1.13
P/FCF Ratio46.37
Enterprise Value/Market Cap1.21
Enterprise Value/Revenue0.88
Enterprise Value/Gross Profit4.18
Enterprise Value/Ebitda-27.97
Forecast
1Y Price Target
$3.35Price Target Upside34.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.11
Revenue Forecast (FY)$1.89B
Bulls Say, Bears Say
Bulls Say
Analyst ConfidenceAnalysts maintain a BUY rating on Clover Health stock, indicating confidence in the company's potential for future growth despite the current challenges.
Growth PotentialClover Health remains committed to aggressive growth and expects improvement from its membership cohort.
Revenue And Profitability GrowthManagement expressed confidence in its ability to drive growth in revenue and profitability into 2026, noting its Clover Assistant technology puts the company in a position to effectively manage medical costs.
Bears Say
Medical Cost ImpactClover Health's higher medical cost trend, particularly from new membership, has negatively impacted the company's profitability.
Profitability ConcernsThe 3Q EBITDA miss and downward profitability guidance revision due to elevated medical costs have created uneasiness among analysts.
Rating DowngradeClover Health's PPO plan received a 3.5-star rating for 2026, down from the 4-stars received in 2025.
Clover Health Investments News
CLOV FAQ
What was Clover Health Investments’s price range in the past 12 months?
Clover Health Investments lowest stock price was $2.12 and its highest was $4.87 in the past 12 months.
What is Clover Health Investments’s market cap?
Clover Health Investments’s market cap is $1.29B.
When is Clover Health Investments’s upcoming earnings report date?
Clover Health Investments’s upcoming earnings report date is Mar 04, 2026 which is in 90 days.
How were Clover Health Investments’s earnings last quarter?
Clover Health Investments released its earnings results on Nov 04, 2025. The company reported -$0.05 earnings per share for the quarter, missing the consensus estimate of -$0.03 by -$0.02.
Is Clover Health Investments overvalued?
According to Wall Street analysts Clover Health Investments’s price is currently Undervalued.
Does Clover Health Investments pay dividends?
Clover Health Investments does not currently pay dividends.
What is Clover Health Investments’s EPS estimate?
Clover Health Investments’s EPS estimate is -0.1.
How many shares outstanding does Clover Health Investments have?
Clover Health Investments has 424,304,900 shares outstanding.
What happened to Clover Health Investments’s price movement after its last earnings report?
Clover Health Investments reported an EPS of -$0.05 in its last earnings report, missing expectations of -$0.03. Following the earnings report the stock price went down -15.909%.
Which hedge fund is a major shareholder of Clover Health Investments?
Currently, no hedge funds are holding shares in CLOV
Clover Health Investments Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.35 (34.00% Upside)
$3.35 (34.00% Upside)
Blogger Sentiment
Bullish
CLOV Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 238.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 3.8%
Last 30 Days ▲ 3.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.19%
12-Months-Change
Fundamentals
Return on Equity
-16.90%
Trailing 12-Months
Asset Growth
-14.30%
Trailing 12-Months
Company Description
Clover Health Investments
Clover Health Investments (CLOV) is a healthcare technology company focused on improving health outcomes and lowering costs for patients. Operating primarily within the Medicare Advantage space, Clover Health utilizes its proprietary software platform, the Clover Assistant, to provide personalized healthcare recommendations to physicians and patients. The company's services are designed to enhance the quality of care while streamlining administrative operations for healthcare providers.
CLOV Company Deck
CLOV Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
While Clover Health reported significant membership and revenue growth, positive EBITDA, and strong retention rates, the call highlighted challenges with new member profitability, lowered financial guidance, and increased medical costs, leading to a balanced outlook.View all CLOV earnings summariesCLOV Stock 12 Month Forecast
Average Price Target
$3.35
▲(34.00% Upside)
Technical Analysis
Ownership Overview
7.01% Insiders
8.25% Mutual Funds
0.44% Other Institutional Investors
74.03% Public Companies and
Individual Investors